Kanghui Shares released its 2026 interim report, with total operating revenue of 205 million yuan, down 17.05 percent year on year, and net profit attributable to the parent of 9.0925 million yuan. Net cash inflow from operating activities was 10.2894 million yuan, the asset-liability ratio was 69.06 percent, gross margin was 35.48 percent, return on equity was 1.70 percent, and diluted earnings per share was 0.09 yuan. The company had 8,318 shareholders, and the top ten shareholders held 55.83 percent of total share capital.
Shaanxi Kanghui Pharm Co LtdInterim report shows revenue down 17.05% YoY and net profit of only 9.09 million yuan, a weak financial result.